RoC Skincare has been acquired by investment group Bridgepoint for an undisclosed sum.
The deal will see the dermatological skin care brand’s current owner Gryphon Investors sell its majority shareholding to Bridgepoint.
Bridgepoint will support RoC Skincare as it aims to grow its business in heritage European markets, particularly its native France.
It is expected to benefit from Bridgepoint’s strong presence in the region and experience in backing dermatological brands, according to the company.
Bridgepoint’s portfolio includes French skin care brand Vivacy and hyaluronic acid producer HTL.
“With Bridgepoint's deep expertise in the dermatology sector and its strong European presence, RoC is poised to capitalise on the promising growth opportunities that lie ahead,” said Fernando Acosta, CEO of RoC Skincare.
“Through the hard work and innovation of RoC's talented team, we've become one of the largest independent skin care brands globally, while upholding our commitment to delivering the best clinically proven skin health solutions.”
Founded in 1957 by Jean-Charles Lissarrague, RoC specialises in skin care products for ageing skin, with its bestsellers including the Retinol Correxion line.
It was acquired by Gryphon Investors from Johnson & Johnson in 2020, and is since said to have experienced a 70% growth in revenue, driven by growing consumer demand for dermo-cosmetic products, according to the company.
Today, the brand is sold across countries including the US, Canada, France, the UK, Australia and China.
"Under Fernando’s leadership, RoC has become an impressive standalone business with a rich European heritage and dermatology expertise,” added Fabrice Turcq, Partner at Bridgepoint.
“The company’s unique, clinically proven products for ageing skin conditions are a highly appealing customer proposition with significant growth opportunities.
“With Bridgepoint’s support, RoC is poised to accelerate growth in Europe and beyond, strengthen its online presence and expand its product offering.”
The deal is expected to close in February.
Read more:
- Pamela Anderson enters skin care with Sonsie. Was make-up free 'rebellion' a PR stunt?
- Puig acquires Dr. Barbara Sturm
- L’Oréal invests in longevity skin care brand Timeline
